3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Leukemia, Myeloid, Acute
71
Precursor Cell Lymphoblastic Leukemia-Lymphoma
64
Myelodysplastic Syndromes
62
Hodgkin Disease
57
Leukemia
56
Leukemia, Lymphocytic, Chronic, B-Cell
55
Multiple Myeloma
51
Lymphoma, Non-Hodgkin
48
Lymphoma
44
Myeloproliferative Disorders
37
Graft vs Host Disease
37
Lymphoma, Follicular
36
Congenital Abnormalities
36
Lymphoma, Large B-Cell, Diffuse
35
Leukemia, Myeloid, Accelerated Phase
35
Lymphoma, Mantle-Cell
34
Lymphoma, B-Cell, Marginal Zone
31
Leukemia, Myeloid, Chronic-Phase
31
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
29
Hematologic Neoplasms
29
Burkitt Lymphoma
28
Leukemia, Myelomonocytic, Chronic
27
Blast Crisis
27
Primary Myelofibrosis
26
Neoplasms, Plasma Cell
25
Lymphoma, Large-Cell, Immunoblastic
25
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
18
Waldenstrom Macroglobulinemia
17
Lymphoma, T-Cell, Cutaneous
16
Anemia, Refractory, with Excess of Blasts
16
Interventions
apixaban
11
Dalteparin
10
Rivaroxaban
7
Enoxaparin
5
Fondaparinux
4
Tinzaparin
3
Heparin, Low-Molecular-Weight
3
Aspirin
3
edoxaban
2
Warfarin
2
Observation
2
Dabigatran
2
sotorasib
1
calcium heparin
1
betrixaban
1
bemiparin
1
argatroban
1
Tacrolimus
1
Tablets
1
Simvastatin
1
Rosuvastatin Calcium
1
Nadroparin
1
Heparin
1
Gemcitabine
1
Drug Therapy
1
Data Collection
1
Cyclosporine
1
AVE 5026
1
ALT-836
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Venous Thromboembolism
×
Tacrolimus
×
Clear all
NCT03083782
2017-10-11
ACT
Thomas Jefferson University
Phase 1
Completed
12 enrolled